Bisphosphonates are a class of drugs that are widely used to inhibit loss of bone mass in patients. We show here that the administration of clinically relevant doses of bisphosphonates in mice increases antibody responses to live and inactive viruses, proteins, haptens, and existing commercial vaccine formulations. Bisphosphonates exert this adjuvant-like activity in the absence of CD4(+) and gamma delta T cells, neutrophils, or dendritic cells, and their effect does not rely on local macrophage depletion, Toll-like receptor signaling, or the inflammasome. Rather, bisphosphonates target directly B cells and enhance B cell expansion and antibody production upon antigen encounter. These data establish bisphosphonates as an additional class of adjuvants that boost humoral immune responses.

Tonti, E., Jiménez de Oya, N., Galliverti, G., Moseman, E.a., Di Lucia, P., Amabile, A., et al. (2013). Bisphosphonates target B cells to enhance humoral immune responses. CELL REPORTS, 5(2), 323-330 [10.1016/j.celrep.2013.09.004].

Bisphosphonates target B cells to enhance humoral immune responses

GENNARI, LUIGI;
2013-01-01

Abstract

Bisphosphonates are a class of drugs that are widely used to inhibit loss of bone mass in patients. We show here that the administration of clinically relevant doses of bisphosphonates in mice increases antibody responses to live and inactive viruses, proteins, haptens, and existing commercial vaccine formulations. Bisphosphonates exert this adjuvant-like activity in the absence of CD4(+) and gamma delta T cells, neutrophils, or dendritic cells, and their effect does not rely on local macrophage depletion, Toll-like receptor signaling, or the inflammasome. Rather, bisphosphonates target directly B cells and enhance B cell expansion and antibody production upon antigen encounter. These data establish bisphosphonates as an additional class of adjuvants that boost humoral immune responses.
2013
Tonti, E., Jiménez de Oya, N., Galliverti, G., Moseman, E.a., Di Lucia, P., Amabile, A., et al. (2013). Bisphosphonates target B cells to enhance humoral immune responses. CELL REPORTS, 5(2), 323-330 [10.1016/j.celrep.2013.09.004].
File in questo prodotto:
File Dimensione Formato  
tonti2013.pdf

accesso aperto

Licenza: DRM non definito
Dimensione 535.34 kB
Formato Adobe PDF
535.34 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/973538